Florence Morin

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14

Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity

Morgane Boulch, Marine Cazaux, Alexis Cuffel et al. · Nature Cancer · 2023 · 132 citations · Full text

Life Sciences, Immunology, Oncology +17

Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France

Jérôme Avouac, Anna Moltó, Véred Abitbol et al. · Seminars in Arthritis and Rheumatism · 2017 · 75 citations

Medicine, Immunology, Pharmacotherapy +13

Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma

Raphaël Liévin, Roberta Di Blasi, Florence Morin et al. · Bone Marrow Transplantation · 2022 · 71 citations · Full text

Medicine, Hematology, Oncology +17